Helen K Reddel1, Susan M Sawyer2, Peter W Everett3, Paul V Flood3, Matthew J Peters4. 1. Woolcock Institute of Medical Research, University of Sydney, NSW, Australia. helen.reddel@sydney.edu.au. 2. Centre for Adolescent Health, Royal Children's Hospital, Melbourne, VIC, Australia. 3. InSync Surveys, Melbourne, VIC, Australia. 4. Concord Repatriation General Hospital, Sydney, NSW, Australia.
Abstract
OBJECTIVE: To identify patterns of asthma control and treatment in Australian adults with asthma. DESIGN: Cross-sectional web-based survey, conducted 1-27 November 2012. PARTICIPANTS: Adults with current asthma, at least 16 years of age, drawn randomly from a web-based panel and weighted to reflect national population proportions for people with asthma. MAIN OUTCOME MEASURES: Asthma Control Test (ACT) scores; health care utilisation; medication use. RESULTS: 2686 participants completed the survey (57.1% female; median age group, 40-49 years). Mean ACT score was 19.2 (95% CI, 18.9-19.3), with asthma classified as "well controlled" for 54.4% of participants, "not well controlled" for 22.7% and "very poorly controlled" for 23.0%. 60.8% reported using preventer medication (mostly combined inhaled corticosteroid/long-acting β2-agonist) during the previous year. 23.4% had made at least one urgent visit to a general practitioner concerning their asthma, 10.0% at least one emergency department visit. Urgent consultations were more common for "very poorly controlled" than "well controlled" asthma (adjusted odds ratio, urgent GP visits 5.98 [95% CI, 4.75-7.54] and emergency department visits 2.59 [95% CI, 1.91-3.53] respectively). Participants were classified according to asthma symptom control and frequency of preventer medication usage: Those with "well controlled" asthma included Group A (40.0% of participants) who used preventer medication infrequently (less than 5 days a week) or not at all, consistent with mild asthma, and Group B (14.7%), who used it at least 5 days a week. Uncontrolled asthma symptoms were reported by Group C (19.7%) despite regular preventer use, and by Group D (25.7%), who used none or little. CONCLUSIONS: This study provides the first data about asthma control and its relationship with treatment in a large representative Australian population. The findings highlight significant preventable asthma morbidity in Australia.
OBJECTIVE: To identify patterns of asthma control and treatment in Australian adults with asthma. DESIGN: Cross-sectional web-based survey, conducted 1-27 November 2012. PARTICIPANTS: Adults with current asthma, at least 16 years of age, drawn randomly from a web-based panel and weighted to reflect national population proportions for people with asthma. MAIN OUTCOME MEASURES: Asthma Control Test (ACT) scores; health care utilisation; medication use. RESULTS: 2686 participants completed the survey (57.1% female; median age group, 40-49 years). Mean ACT score was 19.2 (95% CI, 18.9-19.3), with asthma classified as "well controlled" for 54.4% of participants, "not well controlled" for 22.7% and "very poorly controlled" for 23.0%. 60.8% reported using preventer medication (mostly combined inhaled corticosteroid/long-acting β2-agonist) during the previous year. 23.4% had made at least one urgent visit to a general practitioner concerning their asthma, 10.0% at least one emergency department visit. Urgent consultations were more common for "very poorly controlled" than "well controlled" asthma (adjusted odds ratio, urgent GP visits 5.98 [95% CI, 4.75-7.54] and emergency department visits 2.59 [95% CI, 1.91-3.53] respectively). Participants were classified according to asthma symptom control and frequency of preventer medication usage: Those with "well controlled" asthma included Group A (40.0% of participants) who used preventer medication infrequently (less than 5 days a week) or not at all, consistent with mild asthma, and Group B (14.7%), who used it at least 5 days a week. Uncontrolled asthma symptoms were reported by Group C (19.7%) despite regular preventer use, and by Group D (25.7%), who used none or little. CONCLUSIONS: This study provides the first data about asthma control and its relationship with treatment in a large representative Australian population. The findings highlight significant preventable asthma morbidity in Australia.
Authors: Kerry L Hancock; Sinthia Bosnic-Anticevich; John D Blakey; Mark Hew; Li Ping Chung; Biljana Cvetkovski; Scott Claxton; Peter Del Fante; Eve Denton; Joe Doan; Kanchanamala Ranasinghe; Lucy Morgan; Anita Sharma; Peter K Smith; Deb Stewart; Philip J Thompson; Russell Wiseman; John W Upham; Kwok Y Yan; Victoria Carter; Kiranjeet Dhillon; Florian Heraud; Thao Le; Rebecca Vella; David Price Journal: Pragmat Obs Res Date: 2022-07-05
Authors: Tracey-Lea Laba; Helen K Reddel; Nicholas J Zwar; Guy B Marks; Elizabeth Roughead; Anthony Flynn; Michele Goldman; Aine Heaney; Kirsty Lembke; Stephen Jan Journal: Pharmacoeconomics Date: 2019-02 Impact factor: 4.981
Authors: Kim Watkins; Michelle Trevenen; Kevin Murray; Peter A Kendall; Carl R Schneider; Rhonda Clifford Journal: BMJ Open Date: 2016-08-31 Impact factor: 2.692
Authors: Kim Watkins; Aline Bourdin; Michelle Trevenen; Kevin Murray; Peter A Kendall; Carl R Schneider; Rhonda Clifford Journal: NPJ Prim Care Respir Med Date: 2016-11-24 Impact factor: 2.871
Authors: Karin Lisspers; Pedro Teixeira; Coert Blom; Janwillem Kocks; Björn Ställberg; David Price; Niels Chavannes Journal: NPJ Prim Care Respir Med Date: 2016-04-14 Impact factor: 2.871
Authors: Richard Y Kim; Brittany Rae; Rachel Neal; Chantal Donovan; James Pinkerton; Lohis Balachandran; Malcolm R Starkey; Darryl A Knight; Jay C Horvat; Philip M Hansbro Journal: Clin Transl Immunology Date: 2016-07-15
Authors: Tewodros H Gebremariam; Amsalu B Binegdie; Abebe S Mitiku; Aschalew W Ashagrie; Kibrom G Gebrehiwot; Dawit K Huluka; Charles B Sherman; Neil W Schluger Journal: BMC Res Notes Date: 2017-11-06
Authors: Anna Jetske Baron; Bertine M J Flokstra-de Blok; Huib A M Kerstjens; Gineke Koopmans-Klein; David B Price; Andrea A Sellink; Ioanna Tsiligianni; Janwillem W H Kocks Journal: J Asthma Allergy Date: 2021-07-12